Molecular Government Bids & RFPs

The bid notice states that all responses must be received by May 31st, 2026 at 9:00 am eastern time.

Responses to this notice shall contain sufficient information to establish the interested parties bona fide capabilities for fulfilling the requirement and include a technical proposal, a cost price proposal, the period of performance, the unique entity id uei, the taxpayer identification number tin, and the certification of business size. All offerors must have an active registration in the system for award management sam www. ***. *. *

A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.

The formal sources sought response is due by 05 June 2026 at 10:00 PM PDT.

The government encourages responses from both large and small businesses, including small business, small disadvantaged business, 8a firms, HUBZone firms, woman owned small business (WOSB), economically disadvantaged woman owned small business (EDWOSB), service disabled veteran owned small business (SDVOSB), and veteran owned small business (VOSB). Respondents should provide a capability statement demonstrating their ability to fulfill all requirements identified in the purchase description.

The deadline for submitting responses to this RFI is 1pm EDT on June 17th, 2026. Late responses will not be considered.

This RFI is for information gathering purposes only and does not constitute a request for project proposal nor does it imply any obligation to issue a future solicitation, make any award, or pay any costs associated with responding to this RFI.

Respondents may propose teaming arrangements or partnerships to address the full scope of capabilities described in this RFI. Respondents do not have to be a member of the RRPV consortium to submit a response for this RFI, however, they must be a member of the consortium to respond to any future request for project proposals (RPP) for this requirement.

Proposals must be submitted by 4:00 p. m. local time on June 22, 2026.

The bid notice indicates a cost-reimbursement type contract, with specific invoicing and payment procedures detailed in Article G. 3. Payment requests are to be submitted electronically through the Department of Treasury's Invoice Processing Platform (IPP).

Selection of an offeror for contract award will be based on an evaluation of proposals against three factors: technical, cost, and past performance, with technical factors being of paramount consideration.

Offerors must be registered in the System for Award Management (SAM) and have an active account. The technical proposal must demonstrate understanding of biobanking, tissue handling, and laboratory quality control. Personnel qualifications, facilities suitability, and a detailed technical approach are also crucial.

The bid notice mentions penalties for unallowable costs (FAR Clause ****) and potential termination for convenience or excusable delays. Failure to comply with subcontracting plans can also lead to liquidated damages.

Risks include failure to register in SAM, late proposal submission, non-compliance with Section 508 accessibility standards, supply chain risk assessment findings, and failure to provide required information for responsibility determination.

The bid notice states that respondents must have a demonstrated record of project completion through the sequencing of environmental DNA amplicons on an Illumina NovaSeq **** SP flowcells, including those for federal government research laboratories, and must perform 100% of the requested sequencing service in-house. Additionally, the provider must have 15 or more years of experience providing genomic shotgun and amplicon sequencing services.